Effects of insulin, glimepiride and combination therapy of insulin and metformin on blood sugar and lipid profile of NIDDM patients

Indian Journal of Clinical Biochemistry

Volumn 24, Issue 2, 2009, Pages 175-178

  Valsaraj, Sona ^a   Augusti, K T ^a,c   Chemmanam, Varghese ^b   Jose, Regi ^c  

^a MAHATMA GANDHI UNIVERSITY   (India)

^b Kottayam Medical College   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Blood sugar; Combination therapy; Glimepiride; Insulin; Metformin; NIDDM

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; RECOMBINANT HUMAN INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 74049156299     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12291-009-0031-0     Document Type: Article

References (20)

1. P.S. Van der wal K.E. Draegar A.M. Van Iperen C. Martini M. Aarsen R.J. Heine 1997 B cell response to oral glimepiride administration during and following hyperglycemic clamp in NIDDM patients Diabet Met 14 556 10.1002/(SICI)1096-9136(199707)14:7<556::AID-DIA389>3.0.CO;2-6 (Pubitemid 27298815)
2. K. Geisen A. Vegh E. Krause G. Papp 1996 Cardiovascular effects of conventional sulphonylureas and glimepiride Horm Metab Res 28 496 507 8911987 10.1055/s-2007-979841 1:CAS:528:DyaK28XntVOnsbs%3D
3. R.R. Henry S.V. Edelman 1992 Advances in treatment of NIDDM in the elderly Geriatrics 47 24 1555777
4. J.A. Galloway 1990 Treatment of NIDDM with insulin agonists or substitutes Diabetes Care 13 1209 1239 1980453 10.2337/diacare.13.12.1209 1:STN:280:DyaK3M7hsVCqtw%3D%3D
5. E. Ferrannini M.P. Stern A.Q. Galvan B.D. Mitchell S.M. Haffner 1992 Impact of associated conditions in glycemic control of NIDDM patients Diabetes Care 15 508 1499466 10.2337/diacare.15.4.508 1:STN:280:DyaK38zmt1CrsA%3D%3D
6. K.T. Augusti M.P. Sunil A. Abraham S. Thomas V. Chemmanam 2007 A comparative study on the effects of diet and exercise, metformin and metformin +pioglitazone treatment on NIDDM patients Ind J Clin Biochem 22 2 65 69 10.1007/BF02913316 1:CAS:528:DC%2BD2sXhtVeiurfP (Pubitemid 350224130)
7. P. Trinder 1969 Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor Ann Clin Biochem 6 24 27 1:CAS:528:DyaE3MXotl2itA%3D%3D
8. Chiamori N, Henry R. Total cholesterol, Zlatkis (modified) method, in: Gradwohl's Clinical Laboratory Methods and Diagnosis. Edited by Frankel S, Reitman S, Sonnenwirth AC (The C.V. Mosby company, Saint Louis) 1963, 263p.
9. R.G. Warnick J.A. Albers 1978 A comprehensive evaluation of the heparin- manganese precipitating procedures for estimating high density lipoprotein cholesterol J Lip Res 19 65 76 1:CAS:528:DyaE1cXhtFOguro%3D
10. Chaudhary K. Cholesterol evaluation in: Biochemical techniques. Jaypee Medical Publishers 1989 pp 102-103.
11. Van Handel E, Zilversmit DB. Serum triglycerides: Micromethod; in: Gradwohl's Clinical Laboratory Methods and Diagnosis. Edited by Frankel S, Reitman, S, Sonnenwirth AC (The Mosby Company, Saint Louis) 1963: 263.
12. nd ed. Black Well Scientific Publications, Oxford 1987; 186-196pp.
13. H.N. Ginsberg 1988 Relationship between diabetes mellitus and coronary artery disease Clin Diabetes 6 Supp4 73 94
14. M.R. Taskinen T. Kuusi E. Helve E.A. Nikkila H. Yki-Jarvinen 1988 Insulin therapy induces antiatherogenic changes of serum lipoprotein in NIDDM patients Arteriosclerosis 8 168 177 3279941 1:STN:280:DyaL1c7mt1Kgug%3D%3D
15. F.L. Dunn 1988 Treatment of lipid disorders in DM Med Clin North Am 72 6 1379 1398 3054359 1:STN:280:DyaL1M%2FjvVKrsw%3D%3D
16. G.M. Reaven 1987 Abnormal lipoprotein metabolism in NIDDM; Pathogenesis and treatment Am J Med 83 Suppl3&4 31 40 3307405 10.1016/0002-9343(87)90801-1 1:STN:280:DyaL2szitlarug%3D%3D
17. A. Melander H.E. Lebovitz U.K. Faber 1990 Sulphonyl ureas: Why, which and how? Diabetes Care 13 Suppl3 18 25 2209339
18. L.S. Hermann J.E. Karlson A. Sijostrand 1991 Perspective comparative study in NIDDM using metformin and glibenclamide with special reference to lipid profiles Eur J Clin 41 263 265 10.1007/BF00315441 1:STN:280:DyaK38%2Fotl2isA%3D%3D
19. J.Q. Purnell I.B. Hirsch 1997 New oral therapies for type 2 diabetes Am Family Physician 56 1835 1:STN:280:DyaK1c%2FjvVentQ%3D%3D
20. D.S.H. Bell M.S. Mayo 1997 Outcome of metformin facilitated reinitiation of oral antidiabetic therapy in insulin treated patients with NIDDM Endocrine Practice 3 73 15251479 1:STN:280:DC%2BD2czkvVehug%3D%3D